ICD Co., Ltd. (KOSDAQ:040910)
South Korea · Delayed Price · Currency is KRW 4,500.00
-205.00 (-4.36%)
Jun 5, 2026, 3:30 PM KST
ICD Co., Ltd. Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 202,029 | 197,041 | 147,616 | 62,274 | 150,945 | 115,769 |
Other Revenue | 0 | - | 0 | 0 | - | - |
| 202,029 | 197,041 | 147,616 | 62,274 | 150,945 | 115,769 | |
Revenue Growth (YoY) | 36.38% | 33.48% | 137.04% | -58.74% | 30.38% | -62.53% |
Cost of Revenue | 168,616 | 164,064 | 150,860 | 69,915 | 135,062 | 92,238 |
Gross Profit | 33,413 | 32,978 | -3,244 | -7,641 | 15,883 | 23,532 |
Selling, General & Admin | 22,284 | 23,777 | 19,944 | 19,326 | 18,017 | 17,350 |
Research & Development | 6,298 | 6,298 | 1,435 | 1,105 | 1,270 | 1,256 |
Amortization of Goodwill & Intangibles | 170.1 | 170.1 | 257.01 | 433.24 | 429.94 | 395.29 |
Other Operating Expenses | 308.33 | 308.33 | 378.29 | 691.79 | 281.79 | 287.82 |
Operating Expenses | 27,815 | 29,308 | 23,635 | 31,613 | 21,010 | 21,821 |
Operating Income | 5,598 | 3,670 | -26,880 | -39,254 | -5,127 | 1,711 |
Interest Expense | -1,626 | -1,626 | -2,349 | -1,402 | -1,293 | -242.45 |
Interest & Investment Income | 333.15 | 333.15 | 442.91 | 563.56 | 511.2 | 365.12 |
Earnings From Equity Investments | 53.03 | 53.03 | -304.77 | -1,739 | - | -504.62 |
Currency Exchange Gain (Loss) | -1,197 | -1,197 | 5,135 | 1,648 | 4,908 | 3,876 |
Other Non Operating Income (Expenses) | 901.65 | -590.91 | 6,127 | -5,301 | 693.72 | -1,079 |
EBT Excluding Unusual Items | 4,064 | 643.1 | -17,829 | -45,485 | -306.85 | 4,126 |
Gain (Loss) on Sale of Investments | -212.11 | -212.11 | -210.11 | -228.89 | -253.89 | -114.82 |
Gain (Loss) on Sale of Assets | 334.55 | 334.55 | 11.13 | 199.69 | -5.53 | 100 |
Asset Writedown | - | - | -4,314 | -833.11 | -4,776 | -3,684 |
Other Unusual Items | -2,741 | -2,741 | 952.01 | 633.09 | - | - |
Pretax Income | 1,446 | -1,975 | -21,390 | -45,714 | -5,342 | 427.19 |
Income Tax Expense | 36.47 | 7.58 | 6,912 | -4,396 | 76.86 | -334.62 |
Earnings From Continuing Operations | 1,409 | -1,983 | -28,302 | -41,318 | -5,419 | 761.81 |
Minority Interest in Earnings | 66.15 | 79.54 | 11.64 | - | - | - |
Net Income | 1,475 | -1,903 | -28,291 | -41,318 | -5,419 | 761.81 |
Net Income to Common | 1,475 | -1,903 | -28,291 | -41,318 | -5,419 | 761.81 |
Net Income Growth | - | - | - | - | - | -97.72% |
Shares Outstanding (Basic) | 16 | 16 | 16 | 16 | 16 | 17 |
Shares Outstanding (Diluted) | 16 | 16 | 16 | 16 | 16 | 17 |
Shares Change (YoY) | 0.12% | 0.31% | 1.13% | 0.72% | -4.67% | -1.58% |
EPS (Basic) | 90.33 | -116.56 | -1738.00 | -2566.94 | -339.11 | 45.44 |
EPS (Diluted) | 90.33 | -116.56 | -1738.00 | -2567.00 | -339.11 | 45.00 |
EPS Growth | - | - | - | - | - | -97.72% |
Free Cash Flow | 27,044 | 7,315 | -30,789 | -7,560 | -22,862 | 17,258 |
Free Cash Flow Per Share | 1655.92 | 447.98 | -1891.51 | -469.66 | -1430.56 | 1029.41 |
Gross Margin | 16.54% | 16.74% | -2.20% | -12.27% | 10.52% | 20.33% |
Operating Margin | 2.77% | 1.86% | -18.21% | -63.03% | -3.40% | 1.48% |
Profit Margin | 0.73% | -0.97% | -19.16% | -66.35% | -3.59% | 0.66% |
Free Cash Flow Margin | 13.39% | 3.71% | -20.86% | -12.14% | -15.15% | 14.91% |
EBITDA | 9,621 | 8,175 | -20,445 | -32,372 | 1,438 | 8,731 |
EBITDA Margin | 4.76% | 4.15% | -13.85% | -51.98% | 0.95% | 7.54% |
D&A For EBITDA | 4,023 | 4,505 | 6,435 | 6,882 | 6,565 | 7,020 |
EBIT | 5,598 | 3,670 | -26,880 | -39,254 | -5,127 | 1,711 |
EBIT Margin | 2.77% | 1.86% | -18.21% | -63.03% | -3.40% | 1.48% |
Effective Tax Rate | 2.52% | - | - | - | - | - |
Advertising Expenses | - | - | - | 2 | - | 3 |